|
|
 |
|
|
|
Conference Organisers
The International AIDS Society, IAS
The International AIDS Society, IAS is the world ’s
professional society representing scientists,
clinicians and public health experts engaged
in HIV/AIDS research, prevention, care and
treatment. The IAS has more than 10,000
members representing more than 130 countries,
backed by affiliated regional and national
HIV/AIDS societies such as the Argentine,
British, Canadian, European, Indian, Malaysian,
Spanish, Tanzanian, and United States societies.
Founded in 1988, the IAS is politically and
financially independent and can speak freely
in AIDS controversies.
The IAS is best known for organizing the series
of multidisciplinary International AIDS Conferences
such as the one held in Durban, South Africa
in 2000, the XIV th International AIDS Conference
in Barcelona. The next such Conference will be held
in Bangkok in 2004.
The new series of IAS
Conferences on HIV Pathogenesis and Treatment
represents a new initiative designed to fill an unmet
need in the international scientific community. The
first in this series was held in Buenos Aires in 2001.
The IAS also sponsors regional conferences
in Africa, Asia, Latin America and Europe, as well
as an international education and doctor training
programme for clinicians (IAS-Share).
IAS
participates in many international collaborations,
such as the IAS-CTP clinical trials partnership and
the new WHO-IAS Global HIV Drug Resistance
Monitoring Programme. The IAS international
headquarters are located in Stockholm, Sweden. The official journal of the society is AIDS.
To the IAS website
The French National Agency for AIDS Research (ANRS)
The French National Agency for AIDS Research (ANRS) is pleased to welcome to Paris the Second
International AIDS Society Conference on HIV
Pathogenesis and Treatment. It is no accident
that the IAS has chosen Paris and the ANRS.
The year 2003 marks the 20th anniversary of
the discovery of HIV-1 by French researchers.
And since 1992, France's position in global
HIV/AIDS research has been cemented by the
creation of a public research agency, the ANRS.
The ANRS has sponsored some 120 clinical
trials, and supports many studies in the basic
sciences, pathophysiology, the search for a
preventive vaccine, and the social and economic
sciences. In the last four years, the ANRS has
included among its research priorities the
assessment in the developing world of HIV/AIDS
prevention and access to treatment. The
partnerships forged with numerous institutions
in Europe and beyond have invested the
activities of the ANRS with an international
dimension.
To the ANRS website
|
|
|
|
|
